Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early vs normal bridging intravenous ibandronate to prevent rebound after denosumab discontinuation in postmenopausal osteoporosis
TCTR20240713003Phase 3Completed
- Sponsor
- Ratchadaphiseksomphot Endowment Fund
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of ibandronate in osteoporosis, sponsored by Ratchadaphiseksomphot Endowment Fund. Started Aug 2024; status: completed.
02
Drugs
ibandronate
03
Conditions
osteoporosis
Beyond the preview
Go deeper on TCTR20240713003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20240713003.